Multiechinocandin- and multiazole-resistant Candida parapsilosis isolates serially obtained during therapy for prosthetic valve endocarditis

Varsha Moudgal, Tania Little, Dina Boikov, Jose Antonio Vazquez

Research output: Contribution to journalArticle

211 Citations (Scopus)

Abstract

Echinocandins are approved for the treatment of candidal infections. In vitro they have been shown to be less potent against strains of Candida parapsilosis than against other Candida spp. This is the first case report describing the development of a secondary multidrug (echinocandin-azole)- resistant Candida strain during therapy.

Original languageEnglish (US)
Pages (from-to)767-769
Number of pages3
JournalAntimicrobial Agents and Chemotherapy
Volume49
Issue number2
DOIs
StatePublished - Feb 1 2005

Fingerprint

Endocarditis
Candida
Echinocandins
Azoles
Therapeutics
Infection

ASJC Scopus subject areas

  • Pharmacology (medical)

Cite this

Multiechinocandin- and multiazole-resistant Candida parapsilosis isolates serially obtained during therapy for prosthetic valve endocarditis. / Moudgal, Varsha; Little, Tania; Boikov, Dina; Vazquez, Jose Antonio.

In: Antimicrobial Agents and Chemotherapy, Vol. 49, No. 2, 01.02.2005, p. 767-769.

Research output: Contribution to journalArticle

@article{867bd31d36c841ff879f19a0e3fa7d3a,
title = "Multiechinocandin- and multiazole-resistant Candida parapsilosis isolates serially obtained during therapy for prosthetic valve endocarditis",
abstract = "Echinocandins are approved for the treatment of candidal infections. In vitro they have been shown to be less potent against strains of Candida parapsilosis than against other Candida spp. This is the first case report describing the development of a secondary multidrug (echinocandin-azole)- resistant Candida strain during therapy.",
author = "Varsha Moudgal and Tania Little and Dina Boikov and Vazquez, {Jose Antonio}",
year = "2005",
month = "2",
day = "1",
doi = "10.1128/AAC.49.2.767-769.2005",
language = "English (US)",
volume = "49",
pages = "767--769",
journal = "Antimicrobial Agents and Chemotherapy",
issn = "0066-4804",
publisher = "American Society for Microbiology",
number = "2",

}

TY - JOUR

T1 - Multiechinocandin- and multiazole-resistant Candida parapsilosis isolates serially obtained during therapy for prosthetic valve endocarditis

AU - Moudgal, Varsha

AU - Little, Tania

AU - Boikov, Dina

AU - Vazquez, Jose Antonio

PY - 2005/2/1

Y1 - 2005/2/1

N2 - Echinocandins are approved for the treatment of candidal infections. In vitro they have been shown to be less potent against strains of Candida parapsilosis than against other Candida spp. This is the first case report describing the development of a secondary multidrug (echinocandin-azole)- resistant Candida strain during therapy.

AB - Echinocandins are approved for the treatment of candidal infections. In vitro they have been shown to be less potent against strains of Candida parapsilosis than against other Candida spp. This is the first case report describing the development of a secondary multidrug (echinocandin-azole)- resistant Candida strain during therapy.

UR - http://www.scopus.com/inward/record.url?scp=12944289674&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=12944289674&partnerID=8YFLogxK

U2 - 10.1128/AAC.49.2.767-769.2005

DO - 10.1128/AAC.49.2.767-769.2005

M3 - Article

VL - 49

SP - 767

EP - 769

JO - Antimicrobial Agents and Chemotherapy

JF - Antimicrobial Agents and Chemotherapy

SN - 0066-4804

IS - 2

ER -